Market Overview:
The global hyoscyamine market is expected to grow at a CAGR of 3.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of gastrointestinal disorders, rising geriatric population, and growing demand for generic drugs. In addition, the increasing use of hyoscyamine in hospitals and drug stores is also contributing to the growth of the market. However, stringent regulatory norms and side effects associated with hyoscyamine are restraining the growth of this market. On the basis of type, oral segment dominates the global hyoscyamine market owing to its high usage in hospitals and drug stores for treating various gastrointestinal disorders such as irritable bowel syndrome (IBS), functional dyspepsia (FD), gastroparesis, etc. Injection segment is projected to grow at a higher CAGR during forecast period due its growing demand for treatment of various neurological disorders such as Parkinson’s disease (PD) and spasticity associated with multiple sclerosis (MS). Based on application, hospital segment dominates this market owing to rising number of patients suffering from gastrointestinal disorders that require hospitalization for treatment.
Product Definition:
Hyoscyamine is a naturally occurring tropane alkaloid. It is the levorotary enantiomer of atropine and scopolamine. Hyoscyamine has been used in traditional medicine to treat a wide variety of ills, including digestive problems, respiratory illnesses, and pain.
Oral:
Oral is a form of drug delivery which involves the administration of drugs in the form of tablets, capsules or even injections. The oral route is one of the most popular modes for drug delivery owing to several advantages such as convenience and flexibility in terms dosage forms. It also helps reduce side effects thereby increasing patient compliance.
Advantages associated with oral route medication include quick absorption allowing faster response time, reduced chances for interaction with other medications.
Injection:
Injection is a drug form used for the treatment of stomach and intestinal disorders. It works by relaxing the smooth muscles of the digestive tract, which allows food to pass more quickly through the digestive system. In addition, it also helps in reducing gas and diarrhea caused by certain foods such as milk, coffee or sugar.
Application Insights:
Based on the application, the market is segmented into hospital, drug store and others. The hospital application segment accounted for a major share in 2017 owing to high product usage in hospitals for treating various skin conditions and gastrointestinal disorders. In addition, increasing incidences of motion sickness among children are expected to drive demand over the forecast period.
Hyoscyamine is used as an antinausea agent during surgery which aids patients undergoing any type of surgical procedure such as endoscopy or gastric bypass procedures. It also finds applications as an anti-emetic during chemotherapy sessions which aid patients who suffer from nausea after taking certain medicines or undergoing medical procedures involving radiation therapy or chemotherapy treatment at a drugstore or doctor¢â‚¬â„¢s office outpatient setting.
The other applications include its use by individuals suffering from Parkinson¢â‚¬â„¢s disease and urinary tract infections (UTIs).
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017. The region is expected to maintain its dominance during the forecast period owing to high demand for hyoscyamine-based products and increasing prevalence of CVDs, diabetes, and arthritis among others. In addition, presence of a large number of market players is also expected to drive growth in this region.
Asia Pacific is anticipated to be one of the fastest growing regions with a CAGR exceeding 6.5% from 2018 to 2030 due her rapidly developing healthcare sector coupled with increasing awareness about available treatment options amongst patients suffering from kidney or bladder disorders caused by syphilis or urological problems such as Benign Prostatic Hyperplasia (BPH).
Growth Factors:
- Increasing prevalence of gastrointestinal disorders: The global prevalence of gastrointestinal disorders is increasing due to the changing lifestyle and dietary habits. This is expected to drive the demand for hyoscyamine, as it is used for the treatment of various gastrointestinal disorders.
- Growing awareness about the benefits of hyoscyamine: There is a growing awareness among consumers about the benefits of hyoscyamine, which is expected to drive its demand in the coming years.
- Rising number of product launches: The number of product launches featuring hyoscyamine as an active ingredient has been rising in recent years, owing to its growing popularity among consumers. This is likely to boost growth prospects for the market in future.
- Increasing investment by key players: Key players are investing heavily in research and development activities aimed at developing new formulations and delivery methods for hyoscyamine-based products, which is likely to fuel market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyoscyamine Market Research Report
By Type
Oral, Injection
By Application
Hospital, Drug Store
By Companies
GlaxoSmithKline, Jasper Pharm, Gem Pharmaceuticals, Irza Pharm, Hoechst, Lahore Chemical and Pharmaceutical Works, Genera Pharmaceuticals, Chen-ho Pharmaceuticals, Pfizer, Karo Pharma, Yung Shin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Hyoscyamine Market Report Segments:
The global Hyoscyamine market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Jasper Pharm
- Gem Pharmaceuticals
- Irza Pharm
- Hoechst
- Lahore Chemical and Pharmaceutical Works
- Genera Pharmaceuticals
- Chen-ho Pharmaceuticals
- Pfizer
- Karo Pharma
- Yung Shin Pharmaceutical
Highlights of The Hyoscyamine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyoscyamine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyoscyamine is a medication used to treat anxiety and insomnia. It works by blocking the action of certain chemicals in the brain that can cause these conditions.
Some of the major players in the hyoscyamine market are GlaxoSmithKline, Jasper Pharm, Gem Pharmaceuticals, Irza Pharm, Hoechst, Lahore Chemical and Pharmaceutical Works, Genera Pharmaceuticals, Chen-ho Pharmaceuticals, Pfizer, Karo Pharma, Yung Shin Pharmaceutical.
The hyoscyamine market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyoscyamine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hyoscyamine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hyoscyamine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hyoscyamine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hyoscyamine Market Size & Forecast, 2018-2028
4.5.1 Hyoscyamine Market Size and Y-o-Y Growth
4.5.2 Hyoscyamine Market Absolute $ Opportunity
Chapter 5 Global Hyoscyamine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hyoscyamine Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hyoscyamine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hyoscyamine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hyoscyamine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hyoscyamine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hyoscyamine Analysis and Forecast
9.1 Introduction
9.2 North America Hyoscyamine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hyoscyamine Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hyoscyamine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hyoscyamine Analysis and Forecast
10.1 Introduction
10.2 Europe Hyoscyamine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hyoscyamine Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hyoscyamine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hyoscyamine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hyoscyamine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hyoscyamine Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hyoscyamine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hyoscyamine Analysis and Forecast
12.1 Introduction
12.2 Latin America Hyoscyamine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hyoscyamine Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hyoscyamine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hyoscyamine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hyoscyamine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hyoscyamine Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hyoscyamine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hyoscyamine Market: Competitive Dashboard
14.2 Global Hyoscyamine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Jasper Pharm
14.3.3 Gem Pharmaceuticals
14.3.4 Irza Pharm
14.3.5 Hoechst
14.3.6 Lahore Chemical and Pharmaceutical Works
14.3.7 Genera Pharmaceuticals
14.3.8 Chen-ho Pharmaceuticals
14.3.9 Pfizer
14.3.10 Karo Pharma
14.3.11 Yung Shin Pharmaceutical
